These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 26224222
1. Screening for lupus anticoagulants in patients treated with vitamin K antagonists. Isert M, Miesbach W, Stoever G, Lindhoff-Last E, Linnemann B. Int J Lab Hematol; 2015 Dec; 37(6):758-65. PubMed ID: 26224222 [Abstract] [Full Text] [Related]
2. Taipan snake venom time has high sensitivity for lupus anticoagulants in non-anticoagulated, triple positive antiphospholipid syndrome patients. Moore GW, Platton S, Yartey N, Foxton E, White D, MacDonald SG. Int J Lab Hematol; 2024 Jun; 46(3):538-545. PubMed ID: 38303489 [Abstract] [Full Text] [Related]
7. Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome. Isert M, Miesbach W, Schüttfort G, Weil Y, Tirneci V, Kasper A, Weber A, Lindhoff-Last E, Herrmann E, Linnemann B. Ann Hematol; 2015 Aug; 94(8):1291-9. PubMed ID: 25859986 [Abstract] [Full Text] [Related]
8. Recent guidelines and recommendations for laboratory detection of lupus anticoagulants. Moore GW. Semin Thromb Hemost; 2014 Mar; 40(2):163-71. PubMed ID: 24500573 [Abstract] [Full Text] [Related]
9. Mixing studies in lupus anticoagulant testing are required at least in some type of samples. Devreese KM, de Laat B. J Thromb Haemost; 2015 Aug; 13(8):1475-8. PubMed ID: 26017873 [Abstract] [Full Text] [Related]
10. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population. Lambert M, Ferrard-Sasson G, Dubucquoi S, Hachulla E, Prin L, Hatron PY, Goudemand J, Boffa MC, Caron C. Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423 [Abstract] [Full Text] [Related]
11. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants. Ząbczyk M, Kopytek M, Natorska J, Undas A. Clin Chem Lab Med; 2019 Aug 27; 57(9):1374-1381. PubMed ID: 30763261 [Abstract] [Full Text] [Related]
13. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity. Moore GW, Peyrafitte M, Dunois C, Amiral J. Lupus; 2018 Jan 27; 27(1):95-104. PubMed ID: 28549386 [Abstract] [Full Text] [Related]
15. Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation. Depreter B, Devreese KM. Clin Chem Lab Med; 2016 Sep 01; 54(9):1511-6. PubMed ID: 26894579 [Abstract] [Full Text] [Related]
16. The utility of the Taipan snake venom assay in assessing lupus anticoagulant status in individuals receiving or not receiving an oral vitamin K antagonist. Parmar K, Lefkou E, Doughty H, Connor P, Hunt BJ. Blood Coagul Fibrinolysis; 2009 Jun 01; 20(4):271-5. PubMed ID: 19530340 [Abstract] [Full Text] [Related]
17. Diagnostic accuracy of silica clotting time method for lupus anticoagulant in a clinical population with various symptoms of antiphospholipid syndrome. Averina M, Johannesen S, Brox J. Lupus; 2016 Apr 01; 25(4):418-22. PubMed ID: 26612052 [Abstract] [Full Text] [Related]
18. The association of serum antiphospholipid antibodies and dilute Russell's viper venom times. Froom P, Saffuri-Elias E, Rozenberg O, Barak M. J Clin Pathol; 2014 May 01; 67(5):441-4. PubMed ID: 24327661 [Abstract] [Full Text] [Related]
19. [Usefulness of silica clotting time for detection of lupus anticoagulants]. Lee HR, Kim JE, Ha SH, Kim HK, Park S, Cho HI. Korean J Lab Med; 2009 Dec 01; 29(6):497-504. PubMed ID: 20046079 [Abstract] [Full Text] [Related]